Introduction
Meletios Dimopoulos
Improving treatment outcomes by understanding cytogenetics in
myelodysplastic syndromes
Aristotle Giagounidis
Transfusion independence and cytogenetic response in myelodysplastic syndromes.
What this means for the patient
Alan F. List
Prolonging time to progression and survival in relapsed/refractory
multiple myeloma
Pieter Sonneveld
Targeting the microenvironment: a new treatment paradigm for chronic
lymphocytic leukaemia
Asher Chanan-Khan